Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released a note authored by inventor and ...
IP-2026 introduces 3,340 monographs with blood component, excipient standards to boost patient safety: Shardul Nautiyal, Mumbai Tuesday, January 6, 2026, 08:00 Hrs [IST] In a sign ...
India has significantly enhanced patient safety by implementing uniform pharmacopoeial standards for blood components used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback